Medical Device
Manufacturing
THE TRADE PAPER OF THE FACTORY FLOOR
Z-1103-2019Class II

Abbott ARCHITECT c8000 Processing Module, List No. 01G06 -

Abbott Medical / initiated 2018-07-17 / Terminated / root cause: software

Abbott Laboratories, Inc began a recall of Abbott ARCHITECT c8000 Processing Module, List No. 01G06 - Product Usage: The Abbott ARCHITECT System is intended for In Vitro diagnostic use only. The Abbott... on . FDA classified it as Class II and gives the reason as "There is a potential to generate incorrect results on the instrument if particular error codes are not resolved before transitioning to the Running status". As of , the recall status on record is Terminated, and MDM tags the root cause as software.

Recall record

Recall number
Z-1103-2019
Classification
Class II
Status
Terminated
Initiated
Posted
Terminated
Recalling firm
Abbott Medical
Product
Abbott ARCHITECT c8000 Processing Module, List No. 01G06 - Product Usage: The Abbott ARCHITECT System is intended for In Vitro diagnostic use only. The Abbott ARCHITECT Clinical Chemistry Systems are designed to perform automated chemistry tests, utilizing photometry and potentiometric technology. The ARCHITECT c4000, c8000, c16000 sample pipettor assemblies include a fluid sense/pressure monitoring system that helps identify errors in aspiration.
Product code
JJE Analyzer, Chemistry (Photometric, Discrete), For Clinical Use
Reason for recall
There is a potential to generate incorrect results on the instrument if particular error codes are not resolved before transitioning to the Running status.
Root cause tag
software
FDA root cause
Software design
Action
Recall letters were issued in the U.S. 7/17/2018 via FedEx overnight mail notifying the consignee of the issue, patient impact, and necessary actions to take. Globally, primary methods of issuance were via mail, telephone, and email.
Quantity in commerce
3,794 instruments
Distribution
Worldwide distribution - US Nationwide and countries Afghanistan, Albania, Algeria, Angola, Argentina, Armenia, Australia, Austria, Azerbaijan, Bahamas, Bangladesh, Belarus, Belgium, Bermuda, Bosnia and Herzegovina, Brazil, Brunei, Bulgaria, Burkina FASO, Canada, Cayman Islands, Chile, China, Colombia, Costa Rica, Croatia, Curacao, Cyprus, Czech Republic, Democratic Rep. of Congo, Denmark, Dominican Republic, Ecuador, Egypt, El Salvador, Estonia, Ethiopia, Finland, France, Georgia, Germany, Ghana, Greece, Guatemala, Honduras, Hong Kong, Hungary, India, Indonesia, Iraq, Ireland, Israel, Italy, Ivory Coast, Jamaica, Jordan, Kazakhstan, Kenya, Kuwait, Kyrgyzstan, Latvia, Lebanon, Libya, Lithuania, Luxembourg, Macedonia, Malawi, Malaysia, Maldives, Mali, Mauritania, Mauritius, Mexico, Moldova, Montenegro, Montserrat, Morocco, Myanmar, Netherlands, New Zealand, Nigeria, Norway, Oman, Pakistan, Panama, Paraguay, Peru, Philippines, Poland, Portugal, Qatar, Romania, Russia, Rwanda, Saudi Arabia, Senegal, Serbia, Singapore, Slovakia, Slovenia, South Africa, South Korea, Spain, Sri Lanka, St. Lucia, St. Vincent, Sweden, Switzerland, Taiwan, Tajikistan, Tanzania, Thailand, Trinidad & Tobago, Tunisia, Turk & Caicos, Turkey, UAE, Uganda, UK, Ukraine, Uruguay, Venezuela, Vietnam, Yemen, Zambia, and Zimbabwe.
Product codes and lots
All serial numbers

Enforcement reports

One row per recalled product line
FDA enforcement reports joined to recall event Z-1103-2019
Recall numberClassStatusVoluntary or mandatedReport dateClassified
Z-1102-2019Class IITerminatedVoluntary: Firm initiated
Z-1103-2019Class IITerminatedVoluntary: Firm initiated
Z-1104-2019Class IITerminatedVoluntary: Firm initiated